BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 10657901)

  • 1. CAD, a c-Myc target gene, is not deregulated in Burkitt's lymphoma cell lines.
    Mac SM; Farnham PJ
    Mol Carcinog; 2000 Feb; 27(2):84-96. PubMed ID: 10657901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An E-box-mediated increase in cad transcription at the G1/S-phase boundary is suppressed by inhibitory c-Myc mutants.
    Miltenberger RJ; Sukow KA; Farnham PJ
    Mol Cell Biol; 1995 May; 15(5):2527-35. PubMed ID: 7739536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myc versus USF: discrimination at the cad gene is determined by core promoter elements.
    Boyd KE; Farnham PJ
    Mol Cell Biol; 1997 May; 17(5):2529-37. PubMed ID: 9111322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Start site selection at the TATA-less carbamoyl-phosphate synthase (glutamine-hydrolyzing)/aspartate carbamoyltransferase/dihydroorotase promoter.
    Kollmar R; Sukow KA; Sponagle SK; Farnham PJ
    J Biol Chem; 1994 Jan; 269(3):2252-7. PubMed ID: 7905000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the 5' end of the growth-regulated Syrian hamster CAD gene.
    Farnham PJ; Kollmar R
    Cell Growth Differ; 1990 Apr; 1(4):179-89. PubMed ID: 1982061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular cloning of a human cDNA encoding a trifunctional enzyme of carbamoyl-phosphate synthetase-aspartate transcarbamoylase-dihydroorotase in de Novo pyrimidine synthesis.
    Iwahana H; Fujimura M; Ii S; Kondo M; Moritani M; Takahashi Y; Yamaoka T; Yoshimoto K; Itakura M
    Biochem Biophys Res Commun; 1996 Feb; 219(1):249-55. PubMed ID: 8619816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor/Sp1 complexes are required for induction of cad gene expression by 17beta-estradiol in breast cancer cells.
    Khan S; Abdelrahim M; Samudio I; Safe S
    Endocrinology; 2003 Jun; 144(6):2325-35. PubMed ID: 12746293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct examination of histone acetylation on Myc target genes using chromatin immunoprecipitation.
    Eberhardy SR; D'Cunha CA; Farnham PJ
    J Biol Chem; 2000 Oct; 275(43):33798-805. PubMed ID: 10931841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional repression of human cad gene by hypoxia inducible factor-1alpha.
    Chen KF; Lai YY; Sun HS; Tsai SJ
    Nucleic Acids Res; 2005; 33(16):5190-8. PubMed ID: 16155188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammalian dihydroorotase: nucleotide sequence, peptide sequences, and evolution of the dihydroorotase domain of the multifunctional protein CAD.
    Simmer JP; Kelly RE; Rinker AG; Zimmermann BH; Scully JL; Kim H; Evans DR
    Proc Natl Acad Sci U S A; 1990 Jan; 87(1):174-8. PubMed ID: 1967494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Myc mediates activation of the cad promoter via a post-RNA polymerase II recruitment mechanism.
    Eberhardy SR; Farnham PJ
    J Biol Chem; 2001 Dec; 276(51):48562-71. PubMed ID: 11673469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The intron enhancer of the immunoglobulin kappa gene activates c-myc but does not induce the Burkitt-specific promoter shift.
    Polack A; Strobl L; Feederle R; Schweizer M; Koch E; Eick D; Wiegand H; Bornkamm GW
    Oncogene; 1991 Nov; 6(11):2033-40. PubMed ID: 1945409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revision in sequence of CAD aspartate transcarbamylase domain of Drosophila.
    Davidson JN; Kern CB
    J Mol Biol; 1994 Oct; 243(2):364-6. PubMed ID: 7932764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CAD gene expression in serum-starved and serum-stimulated hamster cells.
    Rao GN; Davidson JN
    DNA; 1988; 7(6):423-32. PubMed ID: 2462483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of the Chinese hamster CAD gene reveals homology between human chromosome 2p and Chinese hamster 7q.
    Bertoni L; Attolini C; Simi S; Giulotto E
    Genomics; 1993 Jun; 16(3):779-81. PubMed ID: 8100805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of cyclin D1 enhances gene amplification.
    Zhou P; Jiang W; Weghorst CM; Weinstein IB
    Cancer Res; 1996 Jan; 56(1):36-9. PubMed ID: 8548770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic instability and apoptosis are frequent in p53 deficient young mice.
    Fukasawa K; Wiener F; Vande Woude GF; Mai S
    Oncogene; 1997 Sep; 15(11):1295-302. PubMed ID: 9315097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MYC abrogates p53-mediated cell cycle arrest in N-(phosphonacetyl)-L-aspartate-treated cells, permitting CAD gene amplification.
    Chernova OB; Chernov MV; Ishizaka Y; Agarwal ML; Stark GR
    Mol Cell Biol; 1998 Jan; 18(1):536-45. PubMed ID: 9418900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heat sensitivity and Sp1 activation of complex formation at the Syrian hamster carbamoyl-phosphate synthase (glutamine-hydrolyzing)/aspartate carbamoyltransferase/dihydroorotase promoter in vitro.
    Kollmar R; Lindstrom MJ; Farnham PJ
    J Biol Chem; 1992 Jan; 267(1):385-91. PubMed ID: 1346130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a phylogenetically conserved Sug1 CAD family member that is differentially expressed in the mouse nervous system.
    Sun D; Swaffield JC; Johnston SA; Milligan CE; Zoeller RT; Schwartz LM
    J Neurobiol; 1997 Dec; 33(7):877-90. PubMed ID: 9407011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.